Skip to main content
. 2021 Jan 22;2021(1):CD013211. doi: 10.1002/14651858.CD013211.pub2

Summary of findings 1. Summary of findings.

Population: Male participants
Intervention: Atorvastatin  
Comparison: Placebo or no treatment
Outcomes Number of participants (RCTs) Mean difference of atorvastatin compared to placebo (95% CI) The certainty of evidence (GRADE)
Total testosterone 140 (2) ‐0.20 nmol/L (‐0.77 to 0.37) Very low 1, 2, 3
Acronyms and grades
*The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: Confidence interval; RCT: randomized controlled trial
GRADE Working Group grades of evidence
High certainty: We are very confident that the true effect lies close to that of the estimate of the effect
Moderate certainty: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different
Low certainty: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect
Very low certainty: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

1 Unclear risk of selection bias.

2 95% confidence interval around the best effect estimate includes both a reduction and an increase in total testosterone.

3 Evidence was derived from only two studies, which had several limitations.